ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1616

Identification of Genes Regulating TRAIL-Induced Apoptosis in Rheumatoid Arthritis Fibroblasts-like Synoviocytes (RA FLS)

Rachel Audo1,2, Bernard Combe3,4, Michael Hahne5 and Jacques Morel6, 1Rheumatology, Teaching Hospital of Lapeyronie, Montpellier, France, 2IGMM, CNRS UMR5535, Montpellier, Montpellier, France, 3Department of Rheumatology, Lapeyronie Hospital, Montpellier, France, 4Montpellier University, Montpellier, France, 5IGMM-CNRS UMR5535, Montpellier, France, 6Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Apoptosis, cytokines, Fibroblasts, rheumatoid arthritis, synovial fluid, synovium and synovial cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

We previously described that sensitivity to TRAIL-induced apoptosis varied in rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) from one patient to another, and was inversly correlated with disease severity. Therefore, we screened for genes differentially expressed in RA FLS sensitive and resistant to TRAIL induced apoptosis.

Methods:

The sensitivity of RAFLS was defined based on the percentage of TRAIL-induced apoptosis: 0-10% for resistant RAFLS (RAFLS-R)  and above 25% for sensitive RAFLS (RAFLS-S). We performed transcriptomic comparison using microarray to compare sensitive (n=6) and resistant RAFLS (n=6).   Differential expression was validated using quantitative PCR (q-RTPCR ) and we examined the implication of identified candidates in the regulation of apoptosis using siRNA . 

Results:

Microarray analysis revealed 10 functional genes differentially expressed according to TRAIL sensitivity. These factors are implicated in different functions, such as the respiratory chain (ND3), the transport of lipids (OSBP2, PLTP), the regulation of signalling linked to extracellular factors (SULF2, GALNT1, SIAE) or the regulation of gene expression (TET2 and LARP6). We confirmed differential expression for GALNT1 (p<0.05) and LARP6  (p<0.05) by q-RTPCR, with an overexpression of LARP6 in RAFLS-R and of GALNT1 in RAFLS-S, while SULF2 also tended to be overexpressed in RAFLS-S (p=0.1). LARP6 protein was also significantly overexpressed in RAFLS-R (n=6) compared to RAFLS-S (n=7) (p<0.05).  Using siRNA extinction, we demonstrated the implication of GALNT1, SULF2 and LARP6 in the control of TRAIL induced responses since the siRNA which target GALNT-1, SULF-2 significantly decreased (p<0.05, n=7) while siRNA targeting LARP6 significantly increased  TRAIL-induced apoptosis of RAFLS (p<0.01, n=10).

DISCUSSION: Concurring with the demonstration of the importance of glycosylation in the regulation of TRAIL sensitivity in cancer cells line , we demonstrated that  GALNT1 and SULF2 are factors participating in TRAIL-induced apoptosis in FLS. We also did the first demonstration that LARP6 participate to the resistance against TRAIL-induced apoptosis.

Conclusion:  To conclude, we described several new potential targets controlling TRAIL induced cell death in RAFLS. These results are of particular interest since GALNT1 and LARP6 have been implicated in the regulation of cell death or in cancer and may represent interesting targets to induce apoptosis of RAFLS.


Disclosure: R. Audo, None; B. Combe, None; M. Hahne, None; J. Morel, None.

To cite this abstract in AMA style:

Audo R, Combe B, Hahne M, Morel J. Identification of Genes Regulating TRAIL-Induced Apoptosis in Rheumatoid Arthritis Fibroblasts-like Synoviocytes (RA FLS) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/identification-of-genes-regulating-trail-induced-apoptosis-in-rheumatoid-arthritis-fibroblasts-like-synoviocytes-ra-fls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-genes-regulating-trail-induced-apoptosis-in-rheumatoid-arthritis-fibroblasts-like-synoviocytes-ra-fls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology